As the pharmaceutical industry environment becomes increasingly complex, pharmaceutical companies are facing more severe challenges:
On one hand, compliance supervision is becoming stricter. Governments continue to strengthen regulation of the pharmaceutical industry, increasing the difficulty of executing marketing activities.
On the other hand, affected by the pandemic, inflation, and other factors, many pharmaceutical companies this year have faced weak revenue growth and rising costs. Some have had to control costs through layoffs, reducing the number of medical representatives and shortening the windows and time for engagement with physicians, which limits business expansion.
Against a backdrop of intensified competition and rising compliance pressure, pharmaceutical companies are accelerating digital and intelligent transformation. Moving from traditional pharmaceutical marketing to data- and intelligence-driven marketing has become inevitable. Through data-driven intelligent decision-making, precision marketing, and other methods, companies can improve operational efficiency and market competitiveness.
Pain Points and Challenges in Data-Driven Precision Marketing for Pharmaceutical Companies
In recent years, data-driven precision marketing has become a shared direction for pharmaceutical companies to explore and practice. Before going further, let us define what it means: it refers to identifying the specific needs and preferences of potential customers through in-depth big data analysis, and then delivering personalized marketing messages based on that information. In essence, pharmaceutical marketing is about providing academic services to physicians and communicating academic content to help improve diagnosis and treatment. The core of physician-centered precision marketing is delivering the right information to the right person at the right time, minimizing wasted resources and improving marketing conversion and efficiency.
Figure 1. Traditional pharmaceutical marketing vs. data-driven intelligent marketing
It is worth noting that pharmaceutical companies commonly encounter the following difficulties when carrying out data-driven intelligent marketing.
- First, traditional data collection is highly subjective: Physician information collected through sales representatives' subjective judgment has limitations and bias, making systematic large-scale data analysis difficult.
- Second, customer insight and data support are lacking: With limited data volume and uneven data quality, pharmaceutical companies cannot fully understand physicians' needs, preferences, prescribing concepts, and other key information, making targeted marketing strategy difficult.
- Third, data management is chaotic: Internal data is scattered and messy, making information hard to manage uniformly. Physician information collected by different departments may be duplicated or inconsistent, making it difficult to form valuable data assets and further worsening inefficient resource use and strategy execution.
Based on these three points, we can see that the core foundation of data-driven marketing lies in mastering data about target physicians. Through big data, companies can understand the individual views and behaviors of different physicians and develop personalized marketing strategies for physicians at different stages. To borrow a phrase we often use with clients: first-grade students read first-grade textbooks, and second-grade students read second-grade textbooks. Strategy should not only be delivered to physicians; it should truly reach them.
HCP360 Physician Profiling Data Insights Drive Pharmaceutical Digital Marketing
As the market environment changes, data development has become a core industry competitiveness. How to use the fewest resources to identify and cover precise target physicians has become a standard question for the industry. Effective marketing strategy depends on accurate physician profiles. Fully understanding and precisely grasping the profile data of target physician groups is undoubtedly the answer that earns full marks.
Since its founding in 2016, MeDomino has helped more than 100 life sciences partners carry out digital and intelligent marketing services. In early 2024, MeDomino invited partners from more than 20 pharmaceutical companies, including multinational and local enterprises, and from departments including medical, marketing, digital, and IT, to discuss how pharmaceutical companies can promote digital and intelligent marketing, share last year's results, and examine the pain points and challenges encountered along the way.
Several interesting topics came up during the meeting:
a. In an environment of major layoffs, how can companies better reach target physicians and understand their needs when business capacity and resources are reduced?
b. Enterprises ask teams to conduct individual attitudinal research with target physicians, but the feedback is poor data quality and low response rates.
c. Business departments lack effective and complete data sources when formulating market strategy, making it hard to build personalized marketing strategies or align execution with business needs.
d. Under compliance requirements, marketing becomes much more difficult, including representative behavior monitoring, financial disclosure requirements, advertising and promotion restrictions, and data privacy protection.
Across these pain points, all parties reached a shared consensus on establishing a complete and comprehensive physician profile library. However, building such a library is not easy and requires the following conditions:
- Master data integration and cleaning: Enterprises have data sources from different channels, including sales visit records, webinar participation data, physicians' professional backgrounds, and prescribing habits. ONE ID integration, master data verification, and data cleaning ensure data accuracy and consistency.
- Construction of physician profile data: Based on integrated data, companies can build refined and comprehensive physician profiles, including professional fields, prescribing habits, online interaction behavior, and more. In-depth analysis reveals the specific needs and preferences of different physician groups.
- Tag-based management of physician profiles: Tags help quickly identify target physician groups and develop personalized marketing strategies based on different physician characteristics. For example, younger physicians may use more online channels such as social media and email, while senior physicians may need more detailed medical materials and research reports.
Figure 2. Business value of physician profiling data across different scenarios
In the process of carrying out digital and intelligent marketing, data construction is only the foundation. Applying data gives enterprises deeper insight into target physicians, but how to deliver precise content to those physicians is another major challenge.
Building an Integrated Digital Marketing Platform to Help Pharmaceutical Companies Implement Strategy
What kind of outcome means a pharmaceutical company has successfully completed its digital marketing transformation?
If building a complete HCP360 physician profile database accounts for 50% of progress in the full marketing loop, then another 40% is certainly internal content management.
At present, enterprise content commonly faces chaotic content asset management, low content production efficiency, and high compliance risk. To address these content management challenges, pharmaceutical companies need to build a comprehensive content management system covering content tagging, content production, asset management, distribution, personalized recommendation, content insight, and other stages. By integrating big data, AI, and other technologies, companies can improve content management efficiency and precision, better serving their marketing goals.
And if 90% of the digital marketing goal has already been achieved, what about the remaining 10%? If you are paying attention to that last 10%, congratulations. In simple terms, the final step requires a platform that connects data and content: NICE (Next Intelligent Customer Experience). NICE is a personalized customer journey management tool that helps enterprises create customized customer journeys. By sending the right message to the right person at the right time, it improves user experience and customer engagement, helping enterprises build continuous, personalized customer experiences and improve conversion and retention. As for how NICE achieves that final 10%?
Read Customer-Centric Closed-Loop Precision Marketing Amid Major Changes in Speaker Fees to find out.
Conclusion
HCP360 physician profiling data is an important tool for pharmaceutical companies' strategy formulation and resource allocation. It is also the foundation for digital and intelligent marketing development, helping companies use data to form evidence-based strategies, coordinate execution across frontline teams, and finally feed results back into a closed-loop solution.
It enables companies to conduct marketing in a more compliant and reasonable way while also reducing costs, improving efficiency, and supporting business growth.
